SaaS - Super Awesome AI Source

Super Awesome AI Source

Sign in Subscribe

SaaS

A collection of 4 posts

We Built the Perfect Per-Tenant AI Agent Isolation Layer. Now We Think It Was a Mistake.

We Built the Perfect Per-Tenant AI Agent Isolation Layer. Now We Think It Was a Mistake.

There is a particular kind of engineering regret that only arrives after you have done something well. Not the regret of shipping something broken, or cutting corners under deadline pressure. This is the quieter, more unsettling kind: the regret of spending months building something elegant, robust, and technically impressive, only

The Quiet Competency Crisis: Why Distributed Systems Masters Are Struggling to Reason About Agentic AI Failure Modes

The Quiet Competency Crisis: Why Distributed Systems Masters Are Struggling to Reason About Agentic AI Failure Modes

There is a specific kind of engineer that every SaaS company spent the last decade desperately recruiting. They could sketch a consensus algorithm on a whiteboard at 9 a.m., debate CAP theorem trade-offs over lunch, and explain exactly why your Kafka consumer group was lagging by Thursday afternoon. They

The Silent Compliance Skip: How One SaaS Team Found a Race Condition Hiding in Their AI Agent Onboarding Pipeline

The Silent Compliance Skip: How One SaaS Team Found a Race Condition Hiding in Their AI Agent Onboarding Pipeline

It started with a routine pre-audit review. A senior engineer at a mid-market SaaS company, let's call them Veridian Labs, was cross-referencing tenant provisioning logs against their compliance audit trail two weeks before a major enterprise client's SOC 2 Type II review. The numbers did not

How a Mid-Size Healthcare SaaS Team Cut Model Retraining Costs by 60% by Ditching Fine-Tuning for a RAG Prompt Caching Architecture

There is a quiet crisis unfolding inside the engineering teams of healthcare SaaS companies right now. It does not show up in product demos or investor decks. It lives in Slack threads at 11pm, in on-call rotations triggered by a model that suddenly started hallucinating drug dosage thresholds, and in